Antonella Tufano

ORCID: 0000-0003-2398-6135
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Blood Coagulation and Thrombosis Mechanisms
  • Central Venous Catheters and Hemodialysis
  • Diagnosis and Treatment of Venous Diseases
  • French Urban and Social Studies
  • Systemic Lupus Erythematosus Research
  • Platelet Disorders and Treatments
  • Acute Myocardial Infarction Research
  • Liver Disease and Transplantation
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Hemophilia Treatment and Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Antiplatelet Therapy and Cardiovascular Diseases
  • COVID-19 Clinical Research Studies
  • Liver Disease Diagnosis and Treatment
  • Complement system in diseases
  • Vascular anomalies and interventions
  • Acute Ischemic Stroke Management
  • Cardiac tumors and thrombi
  • Cerebral Venous Sinus Thrombosis
  • Cardiovascular Function and Risk Factors
  • Growth Hormone and Insulin-like Growth Factors
  • Ultrasound in Clinical Applications
  • Cardiac Imaging and Diagnostics

Federico II University Hospital
2015-2025

University of Naples Federico II
2014-2024

Rambam Health Care Campus
2023

Pegaso University
2015-2022

Institut ACTE - Arts Créations Théories Esthétiques
2022

Centre National de la Recherche Scientifique
2016-2022

Université Paris 1 Panthéon-Sorbonne
2022

Université Gustave Eiffel
2021

Regione Campania
2001-2021

Université Claude Bernard Lyon 1
2021

The efficacy of risk model scores to predict venous thromboembolism (VTE) in ambulatory cancer patients is under investigation, aiming stratify on an individual basis the subset population that could mostly benefit from primary thromboprophylaxis.We prospectively assessed 843 with active cancers, collecting clinical and laboratory data. We screened all a duplex ultrasound (B-mode imaging Doppler waveform analysis) upper lower limbs evaluate right incidence VTE (both asymptomatic...

10.1634/theoncologist.2016-0246 article EN The Oncologist 2017-04-19

Peroxisome proliferator-activated receptor (PPAR)-gamma is a major regulator of adipogenesis and insulin sensitivity. The PPAR-gamma gene generates two isoforms through alternative splicing, PPAR-gamma1 -gamma2, the latter having an additional stretch 28 amino acids at its NH2-terminus in ligand-independent activation domain. This extension renders PPAR-gamma2 more sensitive to action. Since there Pro12Ala substitution this domain, we tested whether it related type 2 diabetes or resistance....

10.2337/diabetes.48.7.1466 article EN Diabetes 1999-07-01

Severe hyperhomocysteinemia due to cystathionine beta-synthase deficiency (CbetaSD) is associated with early atherothrombotic vascular disease. Homocysteine may exert its effects by promoting oxidative damage. In the present study, we investigated whether in vivo formation of 8-iso-prostaglandin (PG) F(2alpha), a platelet-active product arachidonic acid peroxidation, enhanced CbetaSD and it correlates platelet activation, as reflected thromboxane (TX) metabolite excretion.Urine blood samples...

10.1161/hc3501.095287 article EN Circulation 2001-09-04

In patients with venous thromboembolism (VTE), the outcome during course of anticoagulant therapy may differ according to patient's sex. We used RIETE (Registro Informatizado Enfermedad TromboEmbólica) database compare rate VTE recurrences, major bleeding, and mortality due these events sex.As August 2013, 47,499 were enrolled in RIETE, whom 24,280 (51%) women. Women older, more likely presented pulmonary embolism (PE), have recent immobilization but less cancer than men. During...

10.1097/md.0000000000000114 article EN cc-by-nc Medicine 2014-10-01

Abstract. Objectives. To investigate weight loss and reasons for attrition in obese patients on long‐term continuous care. Design. Observational study with 36 months of follow‐up. Setting. Fifteen Italian obesity centres applying a care model medical treatment. Subjects. One thousand treatment‐seeking subjects (785 females, median age 45.1 years, BMI 37.4 kg m −2 ). Weight expectations were systematically recorded at baseline. Interventions. An initial intensive treatment period (3–6 months)...

10.1111/j.1365-2796.2005.01524.x article EN Journal of Internal Medicine 2005-08-19

Each year consumers make a variety of decisions relating to their healthcare. Some experts argue that stronger consumer engagement in about where obtain medical care is an important mechanism for improving efficiency healthcare delivery and financing. Consumers' ability motivation become more active decision makers are affected by several factors, including financial incentives access information. This study investigates the set factors consider when selecting provider, attributes provider...

10.1097/00115514-201103000-00005 article EN Journal of Healthcare Management 2011-03-01
Coming Soon ...